BEUT (Science to Consumers) EBIT: $-0.07 Mil (TTM As of Feb. 2017)


What is Science to Consumers EBIT?

Science to Consumers BEUT EBIT is $-0.07 Mil as of Feb. 2017.

Science to Consumers's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2017 was $-0.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2017 was $-0.07 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Science to Consumers's annualized ROC % for the quarter that ended in Feb. 2017 was -81.82%. Science to Consumers's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2017 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Science to Consumers  (OTCPK:BEUT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Science to Consumers's annualized ROC % for the quarter that ended in Feb. 2017 is calculated as:

ROC % (Q: Feb. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2016 ) + Invested Capital (Q: Feb. 2017 ))/ count )
=-0.036 * ( 1 - 0% )/( (0.04 + 0.048)/ 2 )
=-0.036/0.044
=-81.82 %

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2017) data.

2. Joel Greenblatt's definition of Return on Capital:

Science to Consumers's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2017 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2017 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2016  Q: Feb. 2017
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.072/( ( (0 + max(-0.036, 0)) + (0 + max(-0.044, 0)) )/ 2 )
=-0.072/( ( 0 + 0 )/ 2 )
=-0.072/0
= %

where Working Capital is:

Working Capital(Q: Nov. 2016 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.036 + 0 + 0)
=-0.036

Working Capital(Q: Feb. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.044 + 0 + 0)
=-0.044

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2017) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Science to Consumers's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2017 )
=-0.066/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Science to Consumers EBIT Related Terms


Science to Consumers EBIT Historical Data

* Premium members only.

The historical data trend for Science to Consumers's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Science to Consumers EBIT Chart

Science to Consumers Annual Data
Trend May13 May14 May15 May16
EBIT
0.00 -0.03 -0.05 -0.06

Science to Consumers Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.01 -0.02 -0.02

BEUT vs CAWW, TECR: EBIT Comparison

For the Household & Personal Products subindustry, Science to Consumers's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Science to Consumers EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Science to Consumers's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Science to Consumers's EV-to-EBIT falls into.



Science to Consumers EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.07 Mil mean?
Science to Consumers (BEUT) has a EBIT of $-0.07 Mil as of Feb. 2017. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Science to Consumers.
Is Science to Consumers' EBIT too high?
Science to Consumers' current EBIT is $-0.07 Mil.
How does Science to Consumers' EBIT compare to CAWW and TECR?
Science to Consumers' EBIT of $-0.07 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Science to Consumers. Science to Consumers's current EBIT is $-0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Science to Consumers stock overvalued right now?
Science to Consumers (BEUT) has a current EBIT of $-0.07 Mil. The current EBIT is $-0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Science to Consumers (BEUT), the current EBIT is $-0.07 Mil as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Science to Consumers Business Description

Address 555 Ren Min Road, Room 1618, American Bank Centre, Guangzhou, CHN
Science to Consumers Inc is engaged in the development of anti-aging products. Its products include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after-shave for Men. The company provides direct-to-consumer sales, marketing and distribution of finished consumer skin care products provided by Protein Genomics via direct response advertisements and other globally marketing and distribution channels.